Inhibitor Therapeutics, Inc. — POS AM Filings
4 POS AM filings on record
This page lists all POS AM filings submitted to the SEC by Inhibitor Therapeutics, Inc. (INTI), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibitor Therapeutics, Inc. has filed 4 POS AM documents with the SEC since 1997. To view all SEC filings by Inhibitor Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
10KSB
10KSB/A
10QSB
10QSB/A
15-12B
15-12B/A
25-NSE
3
4
4/A
424B1
424B3
5
8-A12B
8-K
8-K/A
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFR14A
DEFS14A
DFAN14A
EFFECT
NO ACT
NT 10-K
NT 10-Q
NTN 10Q
POS AM
PRE 14A
PRE 14C
PREM14A
PRER14A
PRES14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| POS AM | POS AM | 0001193125-19-122478 | Apr 26, 2019 | — |
| POS AM | POS AM | 0001193125-18-107549 | Apr 4, 2018 | — |
| POS AM | POST - EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001193125-17-131083 | Apr 21, 2017 | — |
| POS AM | CBI FORM SB-2 POST EFFECTIVE AMENDMENT | 0000950168-98-000260 | Feb 2, 1998 | — |